Cosmetic serums containing niacinamide and zinc—sold with claims like 'balances sebum,' 'minimises pores,' or 'reduces redness'—are regulated as cosmetics under FDA jurisdiction. The key distinction to understand is that if you make drug claims such as 'treats acne,' 'kills acne-causing bacteria,' or 'clinically proven to reduce acne lesions,' your product is reclassified as an OTC drug and must comply with the FDA OTC Drug Monograph for acne (which permits only specific active ingredients like benzoyl peroxide, salicylic acid, and adapalene, at defined concentrations). Peptides and zinc PCA do not appear in the OTC acne monograph, so they cannot support drug-level acne claims regardless of their efficacy data.
For a cosmetic positioned with skin-tone, pore, and sebum-balancing language—the safe and common positioning for this formula—the current US regulatory framework post-MoCRA (December 2023) requires:
1. FDA facility registration: Your contract manufacturer must register their facility with the FDA Cosmetic Facility Registration system. This is now mandatory, not voluntary.
2. Ingredient listing submission: Manufacturers must submit ingredient listings to the FDA. If your contract manufacturer is handling production, this is their obligation, but you should confirm it is being met.
3. Responsible person: Under MoCRA, a 'responsible person'—typically the brand owner or the US importer—must ensure the product is safe and properly labeled. This is you, as the brand.
4. INCI labeling: Your label must list all ingredients in descending order of concentration using INCI nomenclature, exactly as required under 21 CFR 701.3. Niacinamide is listed as 'Niacinamide,' zinc PCA as 'Zinc PCA,' and peptides under their INCI names (e.g., Palmitoyl Tripeptide-1, Acetyl Hexapeptide-3).
5. Safety substantiation: You must be able to substantiate that your product is safe. A safety assessment from a qualified cosmetic chemist or toxicologist, accompanied by stability data and a passing challenge test, constitutes standard substantiation.
For California specifically, Prop 65 requires a warning if any listed chemical is present above threshold concentrations. Most properly formulated serums do not trigger this, but confirm with your formulator.
For EU or UK export, the regulatory burden is significantly higher: a Cosmetic Product Safety Report (CPSR) signed by a qualified safety assessor, a Product Information File (PIF), CPNP notification (EU) or SCPN notification (UK), and a named responsible person domiciled in the EU or UK are all required before you can place the product on those markets.
Ingredients in this answer: Salicylic Acid · Niacinamide · Zinc PCA
Read the full guide on Private Label Peptide Zinc Niacinamide Acne Serum Manufacturer →